Urothelial cancer

Description: 
Available test Fluorescence in situ hybridisation analysis of ThinPrep slides using the UroVysion FISH assay
Clinical details: 
The Urovysion FISH assay is intended for use in conjunction with current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer.
Synonyms or keywords: 
UroVysion, urothelial cancer, bladder cancer, transitional cell carcinoma, TCC
Department: 
Genetics Department
Location: 
Guy's Hospital
Sample type and Volume required: 
ThinPrep slide from urine sample
Turnaround time: 
Current service turnaround times: Urgent 2-7 calendar days; Non-urgent 5-10 calendar days; National targets: Urgent samples 95% reported within 14 days; Non-urgent 95% reprted within 21 days
Criteria for acceptance / rejections of sample
Contacts:
Molecular Oncology Unit at Guy's
020 7188 1716
viapath.OncologyDutyScientist@nhs.net
Genetics Department
Southwark Wing - 4th Floor
Guy's Hospital
Great Maze Pond
London SE1 9RT

For clinical advice or interpretation of results, please contact the laboratory in the first instance.
Laboratory: 
Cancer Genetics at Guy's

Print as a PDF

Last updated: 14/08/2025